The Revolving Door of Adenovirus Cell Entry: Not All Pathways Are Equal

Adenoviruses represent exceptional candidates for wide-ranging therapeutic applications, from vectors for gene therapy to oncolytics for cancer treatments. The first ever commercial gene therapy medicine was based on a recombinant adenovirus vector, while most recently, adenoviral vectors have prove...

Descripción completa

Detalles Bibliográficos
Autores principales: Nestić, Davor, Božinović, Ksenija, Pehar, Isabela, Wallace, Rebecca, Parker, Alan L., Majhen, Dragomira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540258/
https://www.ncbi.nlm.nih.gov/pubmed/34683878
http://dx.doi.org/10.3390/pharmaceutics13101585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540258/
https://www.ncbi.nlm.nih.gov/pubmed/34683878
http://dx.doi.org/10.3390/pharmaceutics13101585

Ejemplares similares